Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (9018)	8/27/2003 5:45:01 PM
From: Ian@SI	Respond to of 52153

Latest that I've seen/heard on live news reports here in Canada support the lab screw up theory. Current suspicion is that the common cold went through that old age residence. To date there's not been a single case of pneumonia in the affected population. FWIW, Ian

To: Biomaven who wrote (9018)	9/1/2003 10:50:16 AM
From: Elmer	Read Replies (2) \| Respond to of 52153

To Peter, Richard, MZ, Ice et al A friend's sister has Multiple Sclerosis. Her physician has recently recommended treatment with Rebif. I know that there are may drugs for treatment of the symptoms of MS but only a few that are disease modifying drugs including interferon beta Ia (Avonex and Rebif), interferon beta Ib (Betaseron) and Glatiramer acetate (Copaxone). Do you know of any ongoing clinical trials for new disease modifying drugs for MS? Any help will again be very appreciated. You guys are terrifically generous with your knowledge.